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Background
Patients with mild cognitive impairment (MCI) is
reported to develop Alzheimer's disease (AD) at the rate of
12% per year, greatly exceeding the 1% to 2% incidence of
normal controls. Several studies have shown an increase
in plasma Aβ42 in MCI compared to normal and AD
patients. The efficiency of Aβ peptides elimination in ear-
lier stages of AD has proven in animal models. We found
no study measuring phospho-tau (p-tau) level in plasma.
Materials and methods
We measured the plasma level of Aβ42 and p-tau181 in 7
patients with MCI, 29 AD and 16 normal controls who
had also underwent brain SPECT imaging.
Results
Plasma levels of Aβ42 and p-tau were significantly higher
in MCI (57.9±33.3 pg/ml) (44.5± 91.5pg/ml) comparing
AD (16.3±15.5pg/ml) (3.4±10.7pg/ml) and normal
group (12±7.7pg/ml) (00 pg/ml) (p<0.000) (p<0.010)
respectively.
P-tau was not detectable in normal group but p-tau was
detectable in (57%) (4/7) of patients with MCI and 4
patients with AD. 3 patients with MCI who had high
plasma Aβ42 and detectable p-tau too, had shown bilat-
eral
Posterior temporoparietal hypoperfusion and one
showed not-characteristic perfusion defects in SPECT.
Conclusions
Since high plasma Aβ42 and p-tau in our patients with
MCI were accompanied by perfusion defect characteristic
of AD which is said to be a sign of the progression of MCI
to AD, we suggest the evaluation of plasma Aβ42 and p-
tau as the risk factors of the disease in patients with MCI.
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